These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis.
    Author: Bujold J, Boivin C, Amin M, Bouchard JP, Soucy J.
    Journal: J Cutan Med Surg; 2014; 18(1):69-71. PubMed ID: 24377479.
    Abstract:
    BACKGROUND: Eosinophilic fasciitis is a rare sclerosing syndrome with a poorly understood etiology. OBJECTIVE: We report a case of eosinophilic fasciitis in a 40-year-old man undergoing treatment with natalizumab for multiple sclerosis. Natalizumab is a selective adhesion molecule inhibitor that prevents interaction of leukocytes with endothelial cells. Peripheral blood eosinophilia has been described under treatment with natalizumab, but we herein report the first case to our knowledge of eosinophilic fasciitis as a possible complication of this medication.
    [Abstract] [Full Text] [Related] [New Search]